Seroprevalence of Toxoplasma gondii antibodies in North Indian blood donors: Implications for transfusion transmissible toxoplasmosis

被引:31
作者
Elhence, Priti [1 ]
Agarwal, Prashant [1 ]
Prasad, Kashi Nath [2 ]
Chaudhary, Rajendra K. [1 ]
机构
[1] Sanjay Gandhi Post Grad Inst Med Sci, Dept Transfus Med, Lucknow 226014, Uttar Pradesh, India
[2] Sanjay Gandhi Post Grad Inst Med Sci, Dept Microbiol, Lucknow 226014, Uttar Pradesh, India
关键词
Toxoplasina gondii; Blood donors; Seroprevalence; TRANSPLANT RECIPIENTS; PREVALENCE;
D O I
10.1016/j.transci.2010.05.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Transfusion transmitted Toxoplasma gondii (T. gondii) can result in significant clinical consequences in immunocompromised and multiply transfused patients, pregnant women and fetus etc. Anti-T gondii seroprevalence, specifically IgM antibodies reflect the risk of transfusion transmission. Methods: Four hundred and ninety-three blood donors in a tertiary care hospital in North India were screened for IgG and IgM anti-T. gondii antibodies by enzyme linked immunosorbent assay (ELISA). Results: The prevalence of IgG and IgM anti-T. gondii antibodies was 51.8% and 5% respectively. The prevalence was higher in females (M = 51.6%, F = 89.2%) and in replacement donors (replacement donors = 63.2%, voluntary donors = 33.5%). Conclusion: The donor population constitutes a significant risk of transfusion transmitted toxoplasmosis. Effective strategies are required to prevent transfusion transmitted toxoplasmosis. (c) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:37 / 40
页数:4
相关论文
共 21 条
[1]  
Al-Amari O M, 1994, J Egypt Public Health Assoc, V69, P77
[2]   TOXOPLASMOSIS - CONGENITAL AND IN IMMUNOCOMPROMISED PATIENTS - A PARALLEL [J].
AMBROISETHOMAS, P ;
PELLOUX, H .
PARASITOLOGY TODAY, 1993, 9 (02) :61-63
[3]  
Coêlho Raquel A.L., 2003, Rev. Inst. Med. trop. S. Paulo, V45, P229, DOI 10.1590/S0036-46652003000400011
[4]   Diagnostic implications of kinetics of immunoglobulin M and A antibody responses to Toxoplasma gondii [J].
GorgievskiHrisoho, M ;
Germann, D ;
Matter, L .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (06) :1506-1511
[5]  
Hussein Atef H., 2002, Journal of the Egyptian Society of Parasitology, V32, P639
[6]   RISK OF TRANSMITTING TOXOPLASMOSIS BY BLOOD TRANSFUSION [J].
KIMBALL, AC ;
KEAN, BH ;
KELLNER, A .
TRANSFUSION, 1965, 5 (05) :447-&
[7]   PROVISION OF A PANEL OF ANTI-TOXOPLASMA-NEGATIVE BLOOD-DONORS [J].
MCDONALD, CP ;
BARBARA, JAJ ;
CONTRERAS, M ;
BROWN, S .
VOX SANGUINIS, 1989, 57 (01) :55-58
[8]  
Mollison PL, 1997, BLOOD TRANSFUSION CL, P509
[9]   Toxoplasmosis [J].
Montoya, JG ;
Liesenfeld, O .
LANCET, 2004, 363 (9425) :1965-1976
[10]  
PINOLAR S, 2000, SE ASIAN TROP MED PU, V31, P123